Abstract:Abstract Background The World Health Organization recommended the implementation of antimicrobial stewardship (AMS) in the clinical settings to minimize the development and spread of antimicrobial resistance (AMR). The current study aimed to assess global research activity on AMS as one measure for efforts dedicated to contain AMR. Method A bibliometric method was applied using Scopus. A validated search query was implemented. Bibliometric indicators and mapping were generated. The study period was from 1990 to 2019. The search query utilized the keywords “antimicrobial stewardship” or “antibiotic stewardship” in the titles or abstracts. In addition, documents with the term “restrict” or “restriction” if used with the terms “antimicrobial” or “antibiotic” were retrieved. Results The search query returned 4402 documents. The keyword “antimicrobial stewardship” returned 2849 documents while the keyword “antibiotic stewardship” returned 1718 documents. The terms restrict/restriction and antimicrobial/antibiotics returned 209 documents. The number of publications and cumulative citations showed a steep and parallel increase in the last decade. The region of the Americas returned the most while the Eastern Mediterranean region returned the least. The United States ( n = 1834, 41.7%) ranked first. Main research themes in the retrieved literature were the (1) impact of AMS on hospital length stay, (2) role of pharmacists, and (3) development of resistance of various pathogens. Clostridium difficile ( n = 94) and Staphylococcus aureus ( n = 76) were among the most frequently encountered author keywords. The Infection Control and Hospital Epidemiology journal ranked first ( n = 245, 5.6%, h-index = 134) while documents published in the Clinical Infectious Diseases journal (h-index = 321) received the highest number of citations per document (70.7). At the institutional level, the US Centers for Disease Prevention and Control ( n = 93, 2.1%) ranked first followed by the Imperial College London ( n = 86, 2.0%). The main funding sponsors were the National Institute of Health . Pfizer, Merck, and Bayer pharmaceutical companies played a key role in funding AMS research. International research collaboration between developed ( n = 3693, 83.9%) and developing countries ( n = 759, 17.2%). Conclusion The fight against AMR is a global responsibility and implementation of AMS need to be carried out across the globe. International research collaboration between developing and developed countries should be encouraged.

Analyzing Bacterial Persistence and Dormancy: A Bibliometric Exploration of 21 st Century Scientific Literature

The top 100 cited studies on bacterial persisters: A bibliometric analysis

Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions

Recent Advances in Bacterial Persistence Mechanisms

Environmental, mechanistic and evolutionary landscape of antibiotic persistence

Molecular mechanism and application of emerging technologies in study of bacterial persisters

Bibliometric analysis of peer-reviewed literature on antimicrobial stewardship from 1990 to 2019

Molecular mechanisms of bacterial persistence and phenotypic antibiotic resistance.

Single Cell Growth Rate And Morphological Dynamics Revealing An "Opportunistic" Persistence

Rethinking Dormancy: Antibiotic Persisters are Metabolically Active, Non-Growing Cells

Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication

A Comprehensive Bibliometric Investigation on Antimicrobials from Fungal Origins with a Biotechnological Perspective

A Bibliometric Analysis of Antibacterial Textiles

Bibliometric Analysis of Global Research Output on Antimicrobial Resistance among Pneumonia Pathogens (2013-2023)

Bacterial persisters: molecular mechanisms and therapeutic development

Antimicrobial activity of natural products against MDR bacteria: A scientometric visualization analysis

Definitions and guidelines for research on antibiotic persistence

A bibliometric analysis on discovering anti-quorum sensing agents against clinically relevant pathogens: current status, development, and future directions

Are Bacterial Persisters Dormant Cells Only?

Antibiotic resistance and persistence—Implications for human health and treatment perspectives

A LINK BETWEEN AGING AND PERSISTENCE